BTK-IN-23
BTK-IN-23 is a BTK inhibitor (IC50: 12.8 nM). BTK-IN-23 also inhibits BLX and BMX with IC50s of 35.6 and 5.7 nM respectively. BTK-IN-23 shows improved kinase selectivity compared to Ibrutinib.
Product Specifications
CAS Number
2573048-11-8
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/btk-in-23.html
Solubility
10 mM in DMSO
Smiles
C=CC(N1CCC[C@H](C1)N2N=C(C3=C(N=CN=C32)N)C4=C(C)C=C(C=C4C)OC5=CC=CC=C5)=O
Molecular Formula
C27H28N6O2
Molecular Weight
468.55
References & Citations
[1]Sean T. Toenjes, et al. Controlling Ibrutinib’s Conformations about Its Heterobiaryl Axis to Increase BTK Selectivity. ACS Med. Chem. Lett. 2023. https://doi.org/10.1021/acsmedchemlett.2c00523
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1630166 100 µL
BCL-10 (Phospho-Ser138) Polyclonal Conjugated Antibody
Sign In for Pricing
View Details PT086-5L 1 unit
Westvaco WV5 Medium w/ Vitamins; w/ Vitamins; w/ Vitamins; w/ V
Sign In for Pricing
View Details